Kidney International 2011-03-01

Prevention of vascular calcification: is pyrophosphate therapy a solution?

Veerle P Persy, Marc D McKee

Index: Kidney Int. 79(5) , 490-3, (2011)

Full Text: HTML

Abstract

Pyrophosphate, a ubiquitous small-molecule inhibitor of mineralization abundantly present in the extracellular environment, binds to calcium and mineral surfaces to inhibit crystal growth. O'Neill and colleagues show in uremic rats that systemic administration of pyrophosphate prevents or reduces uremia-related vascular calcification, without overt negative consequences for bone and without calcium pyrophosphate deposition disease. These findings prompt further research into the potential of pyrophosphate as treatment for vascular calcification in chronic kidney disease patients.

Related Compounds

  • Disodium dihydroge...
  • Sodium diphosphate...
  • Tetrasodium pyroph...

Related Articles:

Pharmacological characterization of [3H]VUF11211, a novel radiolabeled small-molecule inverse agonist for the chemokine receptor CXCR3.

2015-04-01

[Mol. Pharmacol. 87(4) , 639-48, (2015)]

Mitochondria-localized NAD biosynthesis by nicotinamide mononucleotide adenylyltransferase in Jerusalem artichoke (Helianthus tuberosus L.) heterotrophic tissues.

2011-10-01

[Planta 234(4) , 657-70, (2011)]

Fabrication of biopolymer-based staple electrospun fibres for nanocomposite applications by particle-assisted low temperature ultrasonication.

2014-12-01

[Mater. Sci. Eng. C. Mater. Biol. Appl. 45 , 277-86, (2014)]

Long-Term In Vitro Degradation of a High-Strength Brushite Cement in Water, PBS, and Serum Solution.

2015-01-01

[Biomed Res. Int. 2015 , 575079, (2015)]

Removal of sidebands in double-rotation NMR in real time.

[J. Magn. Reson. 211(2) , 234-9, (2011)]

More Articles...